BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36617836)

  • 21. Honokiol alleviates ulcerative colitis by targeting PPAR-γ-TLR4-NF-κB signaling and suppressing gasdermin-D-mediated pyroptosis in vivo and in vitro.
    Wang N; Kong R; Han W; Bao W; Shi Y; Ye L; Lu J
    Int Immunopharmacol; 2022 Oct; 111():109058. PubMed ID: 35901530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexmedetomidine alleviates intestinal barrier dysfunction and inflammatory response in mice via suppressing TLR4/MyD88/NF-κB signaling in an experimental model of ulcerative colitis.
    Ye X; Xu H; Xu Y
    Folia Histochem Cytobiol; 2022; 60(4):311-322. PubMed ID: 36504132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perillyl alcohol attenuates chronic restraint stress aggravated dextran sulfate sodium-induced ulcerative colitis by modulating TLR4/NF-κB and JAK2/STAT3 signaling pathways.
    Puppala ER; Aochenlar SL; Shantanu PA; Ahmed S; Jannu AK; Jala A; Yalamarthi SS; Borkar RM; Tripathi DM; Naidu VGM
    Phytomedicine; 2022 Nov; 106():154415. PubMed ID: 36070663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycyrrhiza uralensis Fisch. alleviates dextran sulfate sodium-induced colitis in mice through inhibiting of NF-κB signaling pathways and modulating intestinal microbiota.
    Shi G; Kong J; Wang Y; Xuan Z; Xu F
    J Ethnopharmacol; 2022 Nov; 298():115640. PubMed ID: 36030029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of TRIM8 alleviates dextran sulfate sodium-induced colitis in mice by inhibiting the NF-κB signaling pathway.
    Qiu T; Lv Y; Niu L; Zhang Y
    Allergol Immunopathol (Madr); 2023; 51(1):92-97. PubMed ID: 36617827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BAFF Blockade Attenuates DSS-Induced Chronic Colitis
    Zhang Y; Tao M; Chen C; Zhao X; Feng Q; Chen G; Fu Y
    Front Immunol; 2022; 13():783254. PubMed ID: 35320937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ganluyin ameliorates DSS-induced ulcerative colitis by inhibiting the enteric-origin LPS/TLR4/NF-κB pathway.
    Xiong T; Zheng X; Zhang K; Wu H; Dong Y; Zhou F; Cheng B; Li L; Xu W; Su J; Huang J; Jiang Z; Li B; Zhang B; Lv G; Chen S
    J Ethnopharmacol; 2022 May; 289():115001. PubMed ID: 35085745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mo
    Guo H; Guo H; Xie Y; Chen Y; Lu C; Yang Z; Zhu Y; Ouyang Y; Zhang Y; Wang X
    Redox Biol; 2022 Oct; 56():102441. PubMed ID: 35985164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. l-Isoleucine Administration Alleviates DSS-Induced Colitis by Regulating TLR4/MyD88/NF-κB Pathway in Rats.
    Mao X; Sun R; Wang Q; Chen D; Yu B; He J; Yu J; Luo J; Luo Y; Yan H; Wang J; Wang H; Wang Q
    Front Immunol; 2021; 12():817583. PubMed ID: 35087537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PPARGC1A affects inflammatory responses in photodynamic therapy (PDT)-treated inflammatory bowel disease (IBD).
    Liu C; Jiang Y; Liu G; Guo Z; Jin Q; Long D; Zhou W; Qian K; Zhao H; Liu K
    Biochem Pharmacol; 2022 Aug; 202():115119. PubMed ID: 35667414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systems pharmacology approach uncovers Ligustilide attenuates experimental colitis in mice by inhibiting PPARγ-mediated inflammation pathways.
    Huang Y; Zhang Y; Wan T; Mei Y; Wang Z; Xue J; Luo Y; Li M; Fang S; Pan H; Wang Q; Fang J
    Cell Biol Toxicol; 2021 Feb; 37(1):113-128. PubMed ID: 33130971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flavokawain B inhibits NF-κB inflammatory signaling pathway activation in inflammatory bowel disease by targeting TLR2.
    Chen Y; Jin T; Zhang M; Hong B; Jin B; Hu C; Wang J; Chen Y; Zhang L; Wang Y; Huang L
    Toxicol Appl Pharmacol; 2024 May; 486():116922. PubMed ID: 38583725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of nitric oxide with activation of Toll-like receptor 4 signaling in mice with dextran sodium sulfate-induced colitis.
    Tun X; Yasukawa K; Yamada K
    Free Radic Biol Med; 2014 Sep; 74():108-17. PubMed ID: 24992835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
    Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
    Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phillygenin Attenuated Colon Inflammation and Improved Intestinal Mucosal Barrier in DSS-induced Colitis Mice via TLR4/Src Mediated MAPK and NF-κB Signaling Pathways.
    Xue HH; Li JJ; Li SF; Guo J; Yan RP; Chen TG; Shi XH; Wang JD; Zhang LW
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal alkaline phosphatase ameliorates experimental colitis via toll-like receptor 4-dependent pathway.
    Hwang SW; Kim JH; Lee C; Im JP; Kim JS
    Eur J Pharmacol; 2018 Feb; 820():156-166. PubMed ID: 29247612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis.
    Qu Y; Li X; Xu F; Zhao S; Wu X; Wang Y; Xie J
    Front Immunol; 2021; 12():679897. PubMed ID: 34367139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Jianpi Qingchang decoction alleviates ulcerative colitis by inhibiting nuclear factor-κB activation.
    Zheng L; Zhang YL; Dai YC; Chen X; Chen DL; Dai YT; Tang ZP
    World J Gastroenterol; 2017 Feb; 23(7):1180-1188. PubMed ID: 28275298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium absorption stimulator prostasin (PRSS8) has an anti-inflammatory effect via downregulation of TLR4 signaling in inflammatory bowel disease.
    Sugitani Y; Nishida A; Inatomi O; Ohno M; Imai T; Kawahara M; Kitamura K; Andoh A
    J Gastroenterol; 2020 Apr; 55(4):408-417. PubMed ID: 31916038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.